Operating cash flow decreased 10.8%
Operating cash flow changed -10.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$609.3M→$543.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TROW financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 536 bp lower
Free-cash-flow margin changed -536 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
28.84%→23.47%2 prior comparisons
Operating cash-flow margin moved 508 bp lower
Operating cash-flow margin changed -508 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
32.18%→27.10%2 prior comparisons
Shares outstanding decreased 2.3%
Shares outstanding changed -2.3% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
218,237,000→213,325,9298 prior comparisons
Revenue increased 5.9%
Revenue changed +5.9% from the comparable as-filed period.
$1.9B→$2.0B2 prior comparisons
Stock-based compensation increased 22.5%
Stock-based compensation changed +22.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$37.3M→$45.7M2 prior comparisons
Total assets increased 9.6%
Total assets changed +9.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$14.7B→$16.1B4 prior comparisons
Net income decreased 5.2%
Net income changed -5.2% from the comparable as-filed period.
$646.1M→$612.3M2 prior comparisons
Cash & equivalents increased 3.8%
Cash & equivalents changed +3.8% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.6B→$3.8B4 prior comparisons
SBC / revenue moved 31 bp higher
SBC / revenue changed +31 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.97%→2.28%2 prior comparisons
Capex / revenue moved 28 bp higher
Capex / revenue changed +28 basis points from the comparable as-filed period.
3.34%→3.63%2 prior comparisons
Capital expenditure increased 14.8%
Capital expenditure changed +14.8% from the comparable as-filed period.
$63.3M→$72.7M2 prior comparisons
Operating cash flow / net income decreased 5.9%
Operating cash flow / net income changed -5.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.94→0.892 prior comparisons
Free-cash-flow margin moved 350 bp lower
Free-cash-flow margin changed -350 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.14%→23.64%2 prior comparisons
Operating cash-flow margin moved 363 bp lower
Operating cash-flow margin changed -363 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
30.75%→27.12%2 prior comparisons
Revenue increased 10.7%
Revenue changed +10.7% from the comparable as-filed period.
$1.7B→$1.9B2 prior comparisons
Operating income increased 13.0%
Operating income changed +13.0% from the comparable as-filed period.
$478.3M→$540.5M2 prior comparisons
Free-cash-flow proxy decreased 3.6%
Free-cash-flow proxy changed -3.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$467.7M→$450.9M3 prior comparisons
Operating cash flow decreased 2.4%
Operating cash flow changed -2.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$529.9M→$517.3M3 prior comparisons
Operating margin moved 58 bp higher
Operating margin changed +58 basis points from the comparable as-filed period.
27.75%→28.34%2 prior comparisons
Operating cash flow / net income decreased 22.0%
Operating cash flow / net income changed -22.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.05→0.822 prior comparisons
Total assets increased 7.1%
Total assets changed +7.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$14.3B→$15.4B4 prior comparisons
Cash & equivalents increased 5.7%
Cash & equivalents changed +5.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$3.1B→$3.2B4 prior comparisons
SBC / revenue moved 57 bp lower
SBC / revenue changed -57 basis points from the comparable as-filed period.
2.70%→2.13%2 prior comparisons
Stock-based compensation decreased 12.7%
Stock-based compensation changed -12.7% from the comparable as-filed period.
$46.6M→$40.7M3 prior comparisons
Capex / revenue moved 13 bp lower
Capex / revenue changed -13 basis points from the comparable as-filed period.
3.61%→3.48%2 prior comparisons
Capital expenditure increased 6.8%
Capital expenditure changed +6.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$62.2M→$66.4M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.